Anton Aubanell

Anton Aubanell

Auto-generated profile, based on publicly available information

Anton Aubanell

Hospital de Sant Pau i la Santa Creu, Diagnostic Imaging Department, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Medical Image Analysis
Verified
Journal Article
Closed access
XRXavier Rafael-Palou
Xavier Rafael-Palou
AAAnton Aubanell
Anton Aubanell
IBIlaria Bonavita
Ilaria Bonavita
MCMario Ceresa
Mario Ceresa
Gemma PiellaGemma Piella
Gemma Piella
MBMiguel Ángel González Ballester
Miguel Ángel González Ballester

31 October 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
XRXavier Rafael-Palou
Xavier Rafael-Palou
AAAnton Aubanell
Anton Aubanell
MCMario Ceresa
Mario Ceresa
VRVicente Ribas
Vicente Ribas
Gemma PiellaGemma Piella
Gemma Piella
MBMiguel Ángel González Ballester
Miguel Ángel González Ballester
Predicting whether a lung nodule will grow, remain stable or regress over time, especially early in its follow-up, would help doctors prescribe personalized treatments and better surgical planning. However, the multifactorial nature of lung tumour progression hampers the identification of growth patterns. In this work, we propose a deep hierarchical generative and probabilistic network that, given an initial image of the nodule, predicts whether it will grow, quantifies its future size and provides its expected semantic appearance at a future time. Unlike previous solutions, our approach also estimates the uncertainty in the predictions from the intrinsic noise in medical images and the inter-observer variability in the annotations. The evaluation of this method on an independent test set reported a future tumour growth size mean absolute error of 1.74 mm, a nodule segmentation Dice’s coefficient of 78% and a tumour growth accuracy of 84% on predictions made up to 24 months ahead. Due to the lack of similar methods for providing future lung tumour growth predictions, along with their associated uncertainty, we adapted equivalent deterministic and alternative generative networks (i.e., probabilistic U-Net, Bayesian test dropout and Pix2Pix). Our method outperformed all these methods, corroborating the adequacy of our approach.

11 September 2025 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
MRMeritxell Riera-Marín
Meritxell Riera-Marín
SKSikha O K O K
Sikha O K O K
JRJúlia Rodríguez-Comas
Júlia Rodríguez-Comas
Matthias MayMatthias May
Matthias May
ZPZhaohong Pan
Zhaohong Pan
AGAdrián Galdrán
Adrián Galdrán

9 January 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
MRMeritxell Riera-Marín
Meritxell Riera-Marín
JKJoy-Marie Kleiss
Joy-Marie Kleiss
AAAnton Aubanell
Anton Aubanell
AAAndreu Antolin
Andreu Antolin
JMJuan Moreno-Vedia
Juan Moreno-Vedia
MBMiguel Ángel González Ballester
Miguel Ángel González Ballester
In medical imaging, deep learning (DL) models often struggle to delineate ambiguous structures such as tumors or organ boundaries, leading to uncertainty in defining precise contours. This challenge is amplified by inter-rater variability, where experts may disagree on boundary delineations, resulting in inconsistent segmentation outcomes. Addressing these issues requires robust algorithms capable of quantifying uncertainty, standardizing annotation practices, and improving calibration to ensure reliable predictions, particularly in multi-class and multi-rater scenarios. When models are miscalibrated and overconfident, their outputs can mislead clinical decision-making, potentially influencing radiologists to over- or under-estimate malignancy risks. The CURVAS challenge (Calibration and Uncertainty for multiRater Volume Assessment in multiorgan Segmentation) was established to address these challenges by jointly assessing uncertainty, calibration, and segmentation quality, as well as promoting clinical relevance by evaluating organ volumes while accounting for annotation variability. To support this, a dataset of 90 contrast-enhanced CT scans from University Hospital Erlangen was curated, containing pancreas, liver, and kidney segmentations annotated by three experts. This resource provides a foundation for developing and benchmarking algorithms that balance segmentation accuracy, calibration, and reliability. A quantitative analysis of the annotations shows that kidney and liver segmentations exhibit strong consistency, whereas the pancreas remains challenging, emphasizing the need for refined labeling protocols and improved training strategies.

22 May 2020 in arXiv
Verified
Preprint
Open access
PDF file
XRXavier Rafael-Palou
Xavier Rafael-Palou
AAAnton Aubanell
Anton Aubanell
IBIlaria Bonavita
Ilaria Bonavita
MCMario Ceresa
Mario Ceresa
Gemma PiellaGemma Piella
Gemma Piella
MBMiguel Ángel González Ballester
Miguel Ángel González Ballester
Nodule malignancy assessment is a complex, time-consuming and error-prone task. Current clinical practice requires measuring changes in size and density of the nodule at different time-points. State of the art solutions rely on 3D convolutional neural networks built on pulmonary nodules obtained from single CT scan per patient. In this work, we propose a two-stream 3D convolutional neural network that predicts malignancy by jointly analyzing two pulmonary nodule volumes from the same patient taken at different time-points. Best results achieve 77% of F1-score in test with an increment of 9% and 12% of F1-score with respect to the same network trained with images from a single time-point.